PTC Therapeutics
PTCT
PTCT
196 hedge funds and large institutions have $3.34B invested in PTC Therapeutics in 2020 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 66 increasing their positions, 73 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
10% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 73
3% less funds holding
Funds holding: 202 → 196 (-6)
20% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 30
Holders
196
Holding in Top 10
6
Calls
$15.6M
Puts
$10.2M
Top Buyers
| 1 | +$161M | |
| 2 | +$67.7M | |
| 3 | +$12.5M | |
| 4 |
AC
Armistice Capital
New York
|
+$10.5M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$9.43M |
Top Sellers
| 1 | -$25M | |
| 2 | -$22.2M | |
| 3 | -$16.7M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$16.5M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$13.7M |